105 related articles for article (PubMed ID: 25971646)
1. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation.
Pinkham MB; Telford N; Whitfield GA; Colaco RJ; O'Neill F; McBain CA
Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):445-53. PubMed ID: 25971646
[TBL] [Abstract][Full Text] [Related]
2. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
[TBL] [Abstract][Full Text] [Related]
3. Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms?
Kurdi M; Alkhatabi H; Butt N; Albayjani H; Aljhdali H; Mohamed F; Alsinani T; Baeesa S; Almuhaini E; Al-Ghafari A; Hakamy S; Faizo E; Bahakeem B
Folia Neuropathol; 2021; 59(4):350-358. PubMed ID: 35114775
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M
Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
[TBL] [Abstract][Full Text] [Related]
5. alpha-Internexin expression identifies 1p19q codeleted gliomas.
Ducray F; Crinière E; Idbaih A; Mokhtari K; Marie Y; Paris S; Navarro S; Laigle-Donadey F; Dehais C; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Jan; 72(2):156-61. PubMed ID: 19139367
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue.
Gonzales M; Dale S; Susman M; Mills J
J Clin Neurosci; 2006 Jan; 13(1):96-101. PubMed ID: 16410204
[TBL] [Abstract][Full Text] [Related]
7. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR
Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310
[TBL] [Abstract][Full Text] [Related]
8. False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences.
Alnahhas I; Rayi A; Thomas D; Ong S; Giglio P; Puduvalli V
Am J Clin Oncol; 2020 Nov; 43(11):802-805. PubMed ID: 32889892
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
Singh VY; Chacko G; Chacko AG; Rajshekhar V
Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451
[TBL] [Abstract][Full Text] [Related]
10. Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors.
Jiang H; Ren X; Zhang Z; Zeng W; Wang J; Lin S
J Neurooncol; 2014 Oct; 120(1):131-8. PubMed ID: 25007776
[TBL] [Abstract][Full Text] [Related]
11. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
Rodriguez FJ; Mota RA; Scheithauer BW; Giannini C; Blair H; New KC; Wu KJ; Dickson DW; Jenkins RB
Brain Pathol; 2009 Oct; 19(4):623-9. PubMed ID: 18710393
[TBL] [Abstract][Full Text] [Related]
12. FISHing for 1p19q codel in oligodendroglioma.
Kong PL; Cheah PL; Mun KS; Chiew SF; Lau TP; Koh CC; Teoh KH; Nazarina AR; Looi LM
Malays J Pathol; 2020 Dec; 42(3):369-376. PubMed ID: 33361717
[TBL] [Abstract][Full Text] [Related]
13. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.
Reddy KS
Cancer Genet Cytogenet; 2008 Jul; 184(2):77-86. PubMed ID: 18617055
[TBL] [Abstract][Full Text] [Related]
14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
15. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB
Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596
[TBL] [Abstract][Full Text] [Related]
16. Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours.
Belaud-Rotureau MA; Meunier N; Eimer S; Vital A; Loiseau H; Merlio JP
Acta Neuropathol; 2006 Mar; 111(3):255-63. PubMed ID: 16453145
[TBL] [Abstract][Full Text] [Related]
17. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections.
Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG
Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779
[TBL] [Abstract][Full Text] [Related]
18. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
Gleize V; Alentorn A; Connen de Kérillis L; Labussière M; Nadaradjane AA; Mundwiller E; Ottolenghi C; Mangesius S; Rahimian A; Ducray F; ; Mokhtari K; Villa C; Sanson M
Ann Neurol; 2015 Sep; 78(3):355-74. PubMed ID: 26017892
[TBL] [Abstract][Full Text] [Related]
19. Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.
Durand K; Guillaudeau A; Pommepuy I; Mesturoux L; Chaunavel A; Gadeaud E; Porcheron M; Moreau JJ; Labrousse F
J Clin Pathol; 2011 Sep; 64(9):793-801. PubMed ID: 21653654
[TBL] [Abstract][Full Text] [Related]
20. [Significance and prospects of study on molecular alterations in oligodendrogliomas].
Gresner SM; Liberski PP
Neurol Neurochir Pol; 2007; 41(4):333-9. PubMed ID: 17874342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
